<DOC>
	<DOCNO>NCT02670603</DOCNO>
	<brief_summary>This study prospective randomize control study EVONAIL® solution prevention treatment onycholysis patient breast cancer receive docetaxel chemotherapy .</brief_summary>
	<brief_title>A Trial Evonail® Solution Prevention Treatment Onycholysis</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Onycholysis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Patients breast cancer receive adjuvant/neoadjuvant docetaxel chemotherapy Patients breast cancer receive palliative docetaxel chemotherapy Patients onycholysis docetaxel treatment</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>